InvestorsHub Logo
Followers 0
Posts 1326
Boards Moderated 0
Alias Born 01/25/2016

Re: EOT post# 44884

Monday, 12/16/2019 10:41:20 AM

Monday, December 16, 2019 10:41:20 AM

Post# of 113729
Reason why this remains in trips.

Montreal (Marketwire) - Sunshine Biopharma Inc. (OTCBB: SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has initiated the IND-Enabling studies for Adva-27a, the Company's flagship oncology drug candidate. Adva-27a is a small molecule that has proven effective at killing Multidrug Resistant Breast Cancer cells (MCF-7/MDR) and Small-Cell Lung Cancer cells (H69AR) in vitro. The newly synthesized material which the Company took delivery of ***recently*** has been used to initiate several IND-Enabling experiments which are ***currently in progress.*** Some of these experiments include physical characterization of the molecule as well as various biological activity assays including protein binding, enzyme inhibition, cytotoxicity, in vivo clearance and**** xenograft studies in mice.*** The results of the IND-Enabling studies constitute an integral part of an IND Application (Investigational New Drug Application) which the Company must file with the regulatory authorities in the US and Canada as part of the drug development and approval process.

Starred some of the more relevant words. Lol. Been there done that. Xenograft in mice.....hahahhahah. Still waiting........this was from 2012.

https://www.bioprocessonline.com/doc/sunshine-biopharma-initiates-enabling-studies-anticancer-adva-0001

100% scam! ADVA27A clearly doesnt exist, or does nothing of what they claim, or we would have seen results. This was 7yrs ago!!!!!!

Share selling scam!!

All IMO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News